Coriell Institute made a sizeable impact at a recent biotechnology event. Organized by the International Society for BioProcess Technology (ISBioTech) and staged over the course of three days in Virginia Beach, Virginia, the meeting was an occasion for scientists from non-profit, government and industry research organaizations to discuss emerging trends in biobanking and quality control.
read moreDr. Christman joined Coriell in 2007 and initiated the Coriell Personalized Medicine Collaborative (CPMC), which now involves more than 8,500 participants in 48 states, multiple hospital partners and numerous research collaborators.
read moreCoriell Institute's president and CEO, Dr. Michael Christman, has been acknowledged for his business acumen and contributions to New Jersey industry.
read moreResearch conducted by a partnership between the Coriell Personalized Medicine Collaborative (CPMC) study and the Ohio State University Wexner Medical Center examines the significance of genomic counseling, as it relates to the patient-physician exchange.
read moreDr. Dorit Berlin, Coriell's Director of Biobanking, has been selected by a business publication as one of the region's top researchers in healthcare.
read moreSenator Booker toured the Coriell laboratories while accompanied by United States Representative Donald Norcross (D, first congressional district) and Camden City Mayor Dana Redd.
read moreAs part of a series profiling transformational companies and emergent industry trends, the Philadelphia Business Journal has recognized Coriell Institute and its for-profit spinoff venture, Coriell Life Sciences (CLS), as standout organizations.
read moreAlready possessing the largest publicly available collection of human iPS cell lines, Coriell has crossed the 100 iPS cell line threshold and continues to stimulate important biomedical research at the international level.
read moreIn mid-January, Coriell Institute welcomed one of the nation's most influential healthcare reform experts, Dr. Jeffrey Brenner.
read moreAt a summit of the state's most innovative organizations and thought leaders, the New Jersey Technology Council (NJTC) heralded Coriell Life Sciences (CLS) as 2014's top startup company.
read more